Leiner Health Products Report issue

For profit Phase 3
Founded: Carson CA United States (1973)
Status: Defunct (2002)

Organization Overview

First Clinical Trial
2000
NCT00114400
First Marketed Drug
1986
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Alternative names

LEINER

Active Ingredients

Marketed Drugs (1)

ibuprofen (motrin) (1986)

Drugs in Phase 3 Trials (3)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

pyridoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3